Human Vaccines & Immunotherapeutics

Aims & Scope: Human Vaccines & Immunotherapeutics is the only peer-reviewed journal focused on vaccines and immunotherapeutics for humans. The journal publishes 12 issues per year, mostly as original research articles and reviews, and also features commentaries and news updates. Also included are Special Features of articles and reviews on a focused theme of high interest as well as Special Issues devoted entirely to one such topic or to articles from prestigious international conferences. The journal is fully indexed with a broad and distinguished international panel of Editorial Board members and Associate Editors Editorial Board. The journal enjoys relatively rapid turnaround time from submission to acceptance to publication. Human Vaccines & Immunotherapeutics (HV&I) provides a platform for presenting and discussing cutting-edge research and developments in vaccinology and immunotherapy. Our journal brings together scientists, physicians, public health practitioners, and analysts working in the areas of: research and development of novel vaccines and immunotherapeutics experimental vaccines and novel approaches in vaccination and immunotherapy vaccines and immunotherapeutics for treating non-infectious diseases, e.g., cancer preclinical studies and clinical trials licensed products and their use in the field impact of licensed vaccines and Immunotherapeutics on disease safety and perceptions of licensed vaccines prevention and treatment in the developing world epidemiology and pharmaco-economics HV&I offers a variety of formats including Original Research articles, Short Reports, Case Reports, Reviews, and Commentaries.